{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:28:52Z","timestamp":1771057732009,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.rbmo.2012.01.005","type":"journal-article","created":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T22:51:17Z","timestamp":1327445477000},"page":"410-419","source":"Crossref","is-referenced-by-count":30,"title":["Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH"],"prefix":"10.1016","volume":"24","author":[{"given":"Basil C.","family":"Tarlatzis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Griesinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Leader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luk","family":"Rombauts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieta C.","family":"IJzerman-Boon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette M.J.L.","family":"Mannaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2012.01.005_b0005","first-page":"3","article-title":"Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management","volume":"6","author":"Alper","year":"2009","journal-title":"J. Exp. Clin. Assist. Reprod."},{"key":"10.1016\/j.rbmo.2012.01.005_b0010","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1471-0528.1995.tb10840.x","article-title":"Diagnosis, prevention and management of ovarian hyperstimulation syndrome","volume":"102","author":"Brinsden","year":"1995","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.rbmo.2012.01.005_b0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","article-title":"Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women","volume":"21","author":"Corifollitropin Alfa Ensure Study Group","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.01.005_b0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/clpt.2010.54","article-title":"Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation","volume":"88","author":"De Greef","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.rbmo.2012.01.005_b0025","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2012.01.005_b0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)","volume":"9","author":"Delvigne","year":"2003","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2012.01.005_b0035","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.01.005_b0040","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-free clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.01.005_b0045","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/humrep\/17.8.1987","article-title":"Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females","volume":"17","author":"Duijkers","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.01.005_b0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.01.005_b0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rbmo.2010.06.032","article-title":"Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF","volume":"21","author":"Fauser","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.01.005_b0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2009.12.070","article-title":"Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial","volume":"94","author":"Fatemi","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.01.005_b0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1472-6483(10)60042-9","article-title":"Symposium: update on prediction and management of OHSS. A modern classification of OHSS","volume":"19","author":"Golan","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.01.005_b0070","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.fertnstert.2011.01.163","volume":"95","author":"Griesinger","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.01.005_b0075","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","article-title":"1,500IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study","volume":"93","author":"Humaidan","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.01.005_b0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2010.03.028","article-title":"Preventing ovarian hyperstimulation syndrome: guidance for the clinician","volume":"94","author":"Humaidan","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.01.005_b0085","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2012.01.005_b0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-7827-5-9","article-title":"Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization","volume":"5","author":"Kwee","year":"2007","journal-title":"Reprod. Biol. Endocrinol"},{"key":"10.1016\/j.rbmo.2012.01.005_b0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rbmo.2011.04.002","article-title":"Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response","volume":"23","author":"Ledger","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.01.005_b0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/dem254","article-title":"Serum anti-M\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles","volume":"23","author":"Lee","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.01.005_b0105","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/oxfordjournals.humrep.a138598","article-title":"Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors","volume":"9","author":"Lyons","year":"1994","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.01.005_b0110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","article-title":"Distinction between early and late ovarian hyperstimulation syndrome","volume":"73","author":"Mathur","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.01.005_b0115","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/humrep\/der163","article-title":"Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity","volume":"26","author":"Norman","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2012.01.005_b0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles","volume":"85","author":"Papanikolaou","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2012.01.005_b0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humupd\/dmn001","article-title":"The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis","volume":"14","author":"Verhagen","year":"2008","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2012.01.005_b0130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1472-6483(10)60213-1","article-title":"Optimal follicle and oocyte numbers for cryopreservation of all embryos in IVF cycles at risk of OHSS","volume":"17","author":"Verwoerd","year":"2008","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2012.01.005_b0135","unstructured":"WHO Scientific Group, 1973. Report. World Health Organization, Geneva."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648312000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648312000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T22:50:08Z","timestamp":1543272608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648312000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1472648312000247"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2012.01.005","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}